Finance

Lists
Why is LABT down 8.33%?
Dive Deeper
LABT:NASDAQ
Lakewood-amedex Biotherapeutics Inc
$0.85
-8.33%
(-0.078) 1D
$0.85
-0.57% (-0.0049)
Pre-market
Closed: Oct 5, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LABT...
Open
$0.88
High
$0.88
Low
$0.82
Mkt. cap
2.03M
Avg. vol.
2.13M
Volume
54.59K
52-wk high
$98.20
52-wk low
$0.82
EPS
-$2.91
No. of employees
5
Open
$0.88
High
$0.88
Low
$0.82
Mkt. cap
2.03M
Avg. vol.
2.13M
Volume
54.59K
52-wk high
$98.20
52-wk low
$0.82
EPS
-$2.91
No. of employees
5
News stories
From web sources and news partners
About Lakewood-amedex Biotherapeutics Inc
CEO-
Employees5
Founded2006
Headquarters-
SectorBiotechnology
Websitelakewoodamedex.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
752.93K
185.73K
182.15K
503.02K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
525.17K
703.44K
3.29M
Operating expense
1.88M
712.06K
886.75K
3.79M
Total operating expenses
1.88M
712.06K
886.75K
3.79M
Operating income
-1.88M
-712.06K
-886.75K
-3.79M
Other non operating income
-
-
600.00
-
EBT including unusual items
-1.91M
-744.92K
-923.29K
-3.77M
EBT excluding unusual items
-1.91M
-744.92K
-923.29K
-3.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.91M
-744.92K
-923.29K
-3.77M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
10.97K
4.95K
1.08K
28.28K
Interest expense
-37.81K
-37.81K
-38.22K
-10.63K
Net interest expenses
-26.84K
-32.86K
-37.14K
17.65K
Depreciation and amortization charges
1.16K
1.16K
1.16K
1.16K
EBITDA
-1.88M
-710.90K
-885.59K
-3.79M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps